Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art

被引:142
|
作者
Harpaz, Rave [1 ]
Callahan, Alison [1 ]
Tamang, Suzanne [1 ]
Low, Yen [1 ]
Odgers, David [1 ]
Finlayson, Sam [1 ]
Jung, Kenneth [1 ]
LePendu, Paea [1 ]
Shah, Nigam H. [1 ]
机构
[1] Stanford Univ, Ctr Biomed Informat Res, Stanford, CA 94305 USA
关键词
ELECTRONIC HEALTH RECORDS; SEVERE BONE; SIGNALS; WEB; INFORMATION; ALGORITHMS; DISCOVERY; SCIENCE; DESIGN; CORPUS;
D O I
10.1007/s40264-014-0218-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Text mining is the computational process of extracting meaningful information from large amounts of unstructured text. It is emerging as a tool to leverage underutilized data sources that can improve pharmacovigilance, including the objective of adverse drug event (ADE) detection and assessment. This article provides an overview of recent advances in pharmacovigilance driven by the application of text mining, and discusses several data sources-such as biomedical literature, clinical narratives, product labeling, social media, and Web search logs-that are amenable to text mining for pharmacovigilance. Given the state of the art, it appears text mining can be applied to extract useful ADE-related information from multiple textual sources. Nonetheless, further research is required to address remaining technical challenges associated with the text mining methodologies, and to conclusively determine the relative contribution of each textual source to improving pharmacovigilance.
引用
收藏
页码:777 / 790
页数:14
相关论文
共 50 条
  • [31] Addressing Challenges of Infection: Antibiotic Adverse Drug Events in Older Adults
    Zagaria, Mary Ann E.
    US PHARMACIST, 2019, 44 (04) : 6 - 9
  • [32] Knowledge-based extraction of adverse drug events from biomedical text
    Ning Kang
    Bharat Singh
    Chinh Bui
    Zubair Afzal
    Erik M van Mulligen
    Jan A Kors
    BMC Bioinformatics, 15
  • [33] Knowledge-based extraction of adverse drug events from biomedical text
    Kang, Ning
    Singh, Bharat
    Bui, Chinh
    Afzal, Zubair
    van Mulligen, Erik M.
    Kors, Jan A.
    BMC BIOINFORMATICS, 2014, 15
  • [34] Adverse Drug Events in a Sentinel Hospital in the State of Goias, Brazil
    Bauer de Camargo Silva, Ana Elisa
    Moreira Reis, Adriano Max
    Miasso, Adriana Inocenti
    Santos, Jania Oliveira
    De Bortoli Cassiani, Silvia Helena
    REVISTA LATINO-AMERICANA DE ENFERMAGEM, 2011, 19 (02) : 378 - 386
  • [35] Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
    Kelly, W. N.
    Ho, M. J.
    Smith, T.
    Bullers, K.
    Bates, D. W.
    Kumar, A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (07)
  • [36] INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
    BATES, DW
    CULLEN, DJ
    LAIRD, N
    PETERSEN, LA
    SMALL, SD
    SERVI, D
    LAFFEL, G
    SWEITZER, BJ
    SHEA, BF
    HALLISEY, R
    VANDERVLIET, M
    NEMESKAL, R
    LEAPE, LL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01): : 29 - 34
  • [37] Mining disproportional frequent arrangements of event intervals for investigating adverse drug events
    Lee, Zed
    Rebane, Jonathan
    Papapetrou, Panagiotis
    2020 IEEE 33RD INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS(CBMS 2020), 2020, : 289 - 292
  • [38] Mining reported adverse events induced by potential opioid-drug interactions
    Chen, Jinzhao
    Wu, Gaoyu
    Michelson, Andrew
    Vesoulis, Zachary
    Bogner, Jennifer
    Corrigan, John D.
    Payne, Philip R. O.
    Li, Fuhai
    JAMIA OPEN, 2020, 3 (01) : 104 - 112
  • [39] Intensive Monitoring of Adverse Drug Reactions-State of the Art
    Joaquim, J. J.
    Harmark, L.
    Fontes Ribeiro, C.
    Mateos-Campos, R.
    DRUG SAFETY, 2015, 38 (10) : 992 - 992
  • [40] Management of adverse events in a Moroccan regional hospital: a state of art and perspectives
    Elwardi, Khadija
    Bakkali, Mohammed
    Laglaoui, Amin
    PAN AFRICAN MEDICAL JOURNAL, 2024, 47